Human Mesenchymal Stem Cell-Derived Miniature Joint System for Disease Modeling and Drug Testing.
Human Mesenchymal Stem Cell-Derived Miniature Joint System for Disease Modeling and Drug Testing.
复制标题
人类间充质干细胞衍生的微型关节系统用于疾病建模和药物测试。
DOI:
10.1002/advs.202105909
复制
发表时间:
2022-07
期刊:
影响因子:
15.1
通讯作者:
Lin, Hang
中科院分区:
文献类型:
--
作者:
Li, Zhong;Lin, Zixuan;Liu, Silvia;Yagi, Haruyo;Zhang, Xiurui;Yocum, Lauren;Romero-Lopez, Monica;Rhee, Claire;Makarcyzk, Meagan J.;Yu, Ilhan;Li, Eileen N.;Fritch, Madalyn R.;Gao, Qi;Goh, Kek Boon;O'Donnell, Benjamen;Hao, Tingjun;Alexander, Peter G.;Mahadik, Bhushan;Fisher, John P.;Goodman, Stuart B.;Bunnell, Bruce A.;Tuan, Rocky S.;Lin, Hang
关键词:
Diseases of the knee joint such as osteoarthritis (OA) affect all joint elements. An in vitro human cell‐derived microphysiological system capable of simulating intraarticular tissue crosstalk is desirable for studying etiologies/pathogenesis of joint diseases and testing potential therapeutics. Herein, a human mesenchymal stem cell‐derived miniature joint system (miniJoint) is generated, in which engineered osteochondral complex, synovial‐like fibrous tissue, and adipose tissue are integrated into a microfluidics‐enabled bioreactor. This novel design facilitates different tissues communicating while still maintaining their respective phenotypes. The miniJoint exhibits physiologically relevant changes when exposed to interleukin‐1β mediated inflammation, which are similar to observations in joint diseases in humans. The potential of the miniJoint in predicting in vivo efficacy of drug treatment is confirmed by testing the “therapeutic effect” of the nonsteroidal anti‐inflammatory drug, naproxen, as well as four other potential disease‐modifying OA drugs. The data demonstrate that the miniJoint recapitulates complex tissue interactions, thus providing a robust organ chip model for the study of joint pathology and the development of novel therapeutic interventions. A miniature synovial joint‐mimicking system (miniJoint) is established in a microfluidics‐enabled bioreactor, in which human mesenchymal stem cell‐derived bone‐cartilage complex, synovial‐like fibrous tissue, and adipose tissue are integrated and show active crosstalk. The data demonstrate the potential of miniJoint as a new model for the study of joint pathology and the development of novel therapeutic interventions.
登录
查看更多内容
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
影响因子:
27.4
作者:
Atukorala I;Kwoh CK;Guermazi A;Roemer FW;Boudreau RM;Hannon MJ;Hunter DJ
通讯作者:
Hunter DJ
影响因子:
16.1
作者:
Esch, Mandy B.;Smith, Alec S. T.;Prot, Jean-Matthieu;Oleaga, Carlota;Hickman, James J.;Shuler, Michael L.
通讯作者:
Shuler, Michael L.
影响因子:
7
作者:
de Boer, T. N.;van Spil, W. E.;Mastbergen, S. C.
通讯作者:
Mastbergen, S. C.
影响因子:
7
作者:
Fisch KM;Gamini R;Alvarez-Garcia O;Akagi R;Saito M;Muramatsu Y;Sasho T;Koziol JA;Su AI;Lotz MK
通讯作者:
Lotz MK